Advances in the medical treatment of diabetic retinopathy.
作者信息
Simó Rafael, Hernández Cristina
机构信息
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud CarlosIII, Madrid, Spain.
出版信息
Diabetes Care. 2009 Aug;32(8):1556-62. doi: 10.2337/dc09-0565.
Abstract
摘要
相似文献
1
Advances in the medical treatment of diabetic retinopathy.糖尿病视网膜病变的医学治疗进展
Diabetes Care. 2009 Aug;32(8):1556-62. doi: 10.2337/dc09-0565.
2
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.超越低密度脂蛋白：应对2型糖尿病和代谢综合征中的致动脉粥样硬化脂质三联征。
Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005.
3
[How to treat dyslipidemia in patients with metabolic syndrome].[如何治疗代谢综合征患者的血脂异常]
Vnitr Lek. 2015 Jul-Aug;61(7-8):721-4.
4
Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.印度南部城市地区血清脂质与糖尿病视网膜病变的关联——金奈城乡流行病学研究（CURES）眼部研究——2
Diabet Med. 2006 Sep;23(9):1029-36. doi: 10.1111/j.1464-5491.2006.01890.x.
5
The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy.引入可治疗糖尿病视网膜病变早期检测筛查计划后的五年失明发生率。
Diabet Med. 1993 Jul;10(6):555-9. doi: 10.1111/j.1464-5491.1993.tb00120.x.
6
[Results of laser photocoagulation in diabetic retinopathy with maculopathy].
Klin Oczna. 1991 Oct-Nov;93(10-11):306-7.
7
Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.2型糖尿病和糖尿病视网膜病变患者中他汀类药物使用及高甘油三酯血症与糖尿病性黄斑水肿的关联
Cardiovasc Diabetol. 2017 Jan 7;16(1):4. doi: 10.1186/s12933-016-0486-2.
8
Fibrates and statins in the treatment of diabetic retinopathy.贝特类药物和他汀类药物治疗糖尿病性视网膜病变。
Curr Pharm Biotechnol. 2011 Mar 1;12(3):396-405. doi: 10.2174/138920111794480570.
9
Active prevention in diabetic eye disease. A 4-year follow-up.糖尿病眼病的积极预防。一项为期4年的随访研究。
Acta Ophthalmol Scand. 1997 Jun;75(3):249-54. doi: 10.1111/j.1600-0420.1997.tb00766.x.
10
Retinopathy progression in type 2 diabetes.2型糖尿病视网膜病变的进展
N Engl J Med. 2010 Nov 25;363(22):2172; author reply 2173-4. doi: 10.1056/NEJMc1009236.
引用本文的文献
1
Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration.糖尿病视网膜病变与阿尔茨海默病：神经退行性变中未折叠蛋白反应的交汇
Alzheimers Dement. 2025 Aug;21(8):e70497. doi: 10.1002/alz.70497.
2
Meta-analysis: long/short-term efficacy of anti-VEGF vs. panretinal photocoagulation in preventing severe complications in proliferative diabetic retinopathy.荟萃分析：抗血管内皮生长因子与全视网膜光凝在预防增殖性糖尿病视网膜病变严重并发症方面的长期/短期疗效
Int J Retina Vitreous. 2025 Jul 9;11(1):76. doi: 10.1186/s40942-025-00687-0.
3
Factors Associated with Adherence to Diabetic Retinopathy Screening Among Patients Attending a Nurse-Led Community Clinic in Australia: A Qualitative Study.澳大利亚一家由护士主导的社区诊所中患者糖尿病视网膜病变筛查依从性的相关因素：一项定性研究
Nurs Rep. 2025 Jan 14;15(1):23. doi: 10.3390/nursrep15010023.
4
TNFSF15 inhibits progression of diabetic retinopathy by blocking pyroptosis via interacting with GSDME.肿瘤坏死因子超家族成员 15 通过与 GSDME 相互作用阻断焦亡来抑制糖尿病视网膜病变的进展。
Cell Death Dis. 2024 Feb 8;15(2):118. doi: 10.1038/s41419-024-06499-8.
5
Neuritin Alleviates Diabetic Retinopathy by Regulating Endoplasmic Reticulum Stress in Rats.神经黏附素通过调节内质网应激缓解大鼠糖尿病视网膜病变。
Comb Chem High Throughput Screen. 2024;27(16):2454-2461. doi: 10.2174/0113862073275316231123060640.
6
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy.基于代谢组学的糖尿病视网膜病变研究的最新进展与展望
Metabolites. 2023 Sep 12;13(9):1007. doi: 10.3390/metabo13091007.
7
Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats.富含外泌体的羊膜间充质干细胞条件培养基对大鼠糖尿病视网膜病变的预防作用。
Transl Vis Sci Technol. 2023 Aug 1;12(8):18. doi: 10.1167/tvst.12.8.18.
8
Biomaterial Drug Delivery Systems for Prominent Ocular Diseases.用于常见眼部疾病的生物材料药物递送系统
Pharmaceutics. 2023 Jul 15;15(7):1959. doi: 10.3390/pharmaceutics15071959.
9
Optical Identification of Diabetic Retinopathy Using Hyperspectral Imaging.利用高光谱成像技术对糖尿病视网膜病变进行光学识别。
J Pers Med. 2023 Jun 1;13(6):939. doi: 10.3390/jpm13060939.
10
Study on the Prognosis Effect of Traditional Chinese Medicine Treatment in DR Patients Based on the Perspective of Network Pharmacology.基于网络药理学视角的 DR 患者中医药治疗预后效果研究。
Contrast Media Mol Imaging. 2022 Jul 19;2022:3528732. doi: 10.1155/2022/3528732. eCollection 2022.
本文引用的文献
1
Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.糖尿病视网膜神经变性与线粒体氧化应激相关，在高血压合并糖尿病模型中，血管紧张素受体阻滞剂可改善这种情况。
Diabetes. 2009 Jun;58(6):1382-90. doi: 10.2337/db09-0166. Epub 2009 Mar 16.
2
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.一项比较局灶/格栅光凝与玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿的随机试验的三年随访
Arch Ophthalmol. 2009 Mar;127(3):245-51. doi: 10.1001/archophthalmol.2008.610.
3
Intravitreal bevacizumab for diabetic retinopathy.玻璃体内注射贝伐单抗治疗糖尿病性视网膜病变。
Curr Diabetes Rev. 2009 Feb;5(1):39-46. doi: 10.2174/157339909787314121.
4
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.一项关于糖尿病性黄斑水肿患者单次玻璃体内注射血管内皮生长因子 Trap-Eye 的安全性、耐受性和生物活性的探索性研究。
Br J Ophthalmol. 2009 Feb;93(2):144-9. doi: 10.1136/bjo.2008.138271.
5
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.血管紧张素II的阻断可减轻糖尿病视网膜病变中血管内皮生长因子介导的血视网膜屏障破坏。
J Cereb Blood Flow Metab. 2009 Mar;29(3):621-8. doi: 10.1038/jcbfm.2008.154. Epub 2008 Dec 24.
6
Fenofibrate: treatment of hyperlipidemia and beyond.非诺贝特：高脂血症及其他病症的治疗
Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1319-30. doi: 10.1586/14779072.6.10.1319.
7
Vascular endothelial growth factor and diabetic complications.血管内皮生长因子与糖尿病并发症
Prog Retin Eye Res. 2008 Nov;27(6):608-21. doi: 10.1016/j.preteyeres.2008.09.002. Epub 2008 Oct 1.
8
Apolipoprotein A1 is overexpressed in the retina of diabetic patients.载脂蛋白A1在糖尿病患者的视网膜中过度表达。
Am J Ophthalmol. 2009 Feb;147(2):319-325.e1. doi: 10.1016/j.ajo.2008.08.009. Epub 2008 Oct 9.
9
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.坎地沙坦对2型糖尿病视网膜病变进展和逆转的影响（DIRECT-Protect 2）：一项随机安慰剂对照试验。
Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.
10
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.坎地沙坦对1型糖尿病视网膜病变预防（DIRECT-Prevent 1）和进展（DIRECT-Protect 1）的作用：随机、安慰剂对照试验。
Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.
Zotero 插件